A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.

Russell RK, Wilson ML, Loganathan S, Bourke B, Kiparissi F, Mahdi G, Torrente F, Rodrigues A, Davies I, Thomas A, Akobeng AK, Fagbemi A, Hyer W, Spray C, Vaish S, Rogers P, McGrogan P, Heuschkel RB, Ayub N, Fell JM, Afzal NA, Green M, Murphy MS, Rao P, Shah N, Ho GT, Naik S, Wilson DC

Open source

DOI: 10.1111/j.1365-2036.2011.04603.x
Published: 2011 Apr
Container: Alimentary pharmacology & therapeutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/j.1365-2036.2011.04603.x,
  title = {A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.},
  author = {Russell RK and Wilson ML and Loganathan S and Bourke B and Kiparissi F and Mahdi G and Torrente F and Rodrigues A and Davies I and Thomas A and Akobeng AK and Fagbemi A and Hyer W and Spray C and Vaish S and Rogers P and McGrogan P and Heuschkel RB and Ayub N and Fell JM and Afzal NA and Green M and Murphy MS and Rao P and Shah N and Ho GT and Naik S and Wilson DC},
  year = {2011},
  journal = {Alimentary pharmacology \& therapeutics},
  doi = {10.1111/j.1365-2036.2011.04603.x},
  url = {https://doi.org/10.1111/j.1365-2036.2011.04603.x}
}

RIS

TY  - JOUR
TI  - A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.
AU  - Russell RK
AU  - Wilson ML
AU  - Loganathan S
AU  - Bourke B
AU  - Kiparissi F
AU  - Mahdi G
AU  - Torrente F
AU  - Rodrigues A
AU  - Davies I
AU  - Thomas A
AU  - Akobeng AK
AU  - Fagbemi A
AU  - Hyer W
AU  - Spray C
AU  - Vaish S
AU  - Rogers P
AU  - McGrogan P
AU  - Heuschkel RB
AU  - Ayub N
AU  - Fell JM
AU  - Afzal NA
AU  - Green M
AU  - Murphy MS
AU  - Rao P
AU  - Shah N
AU  - Ho GT
AU  - Naik S
AU  - Wilson DC
PY  - 2011
JO  - Alimentary pharmacology & therapeutics
DO  - 10.1111/j.1365-2036.2011.04603.x
UR  - https://doi.org/10.1111/j.1365-2036.2011.04603.x
ER  -

APA

RK, R., ML, W., S, L., B, B., F, K., G, M., F, T., A, R., I, D., A, T., AK, A., A, F., W, H., C, S., S, V., P, R., P, M., RB, H., N, A., JM, F., NA, A., M, G., MS, M., P, R., N, S., GT, H., S, N., & DC, W. (2011). A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/j.1365-2036.2011.04603.x

Source records

pubmed · retrieved 2026-09-25T22:48:25.820Z